Investigation into fluoroquinolone antibiotics. Cipro, Levaquin, Avelox, Floxin, and other fluoroquinolones. This petition requests that the United States Congress and the European Commission, ( European Medicines Agency ) take action against the long term and sometimes permanent disabling effects of fluoroquinolone antibiotics. Long term adverse effects include but are not limited to: tendon rupture, tendonitis, neuropathy, depression, anxiety, suicidal ideation, toxic psychosis, liver damage, kidney damage, vision disorders, cardiovascular damage, depersonalization, paranoia, tremors, vertigo, cognitive dysfunction, seizures, and insomnia. Fluoroquinolone antibiotics are currently one of the most commonly prescribed classes of antibiotics on the market. The manufacturers and the FDA have turned a blind eye to the severe and disabling drug reactions associated with these antibiotics. Victims have suffered long term consequences from as little as a one pill. These toxic reactions have lead to the loss of earning, career, and family. Approximately half of all the fluoroquinolone antibiotics that were once on the market have now been removed from clinical practice. The insidious nature of these long term disabling reactions is that they can occur many weeks to months after cessation of the antibiotic. Hence, many people never link their injuries back to the drug because of the delayed toxicity profile of fluoroquinolones. Moreover, if a first association to fluoroquinolones and adverse symptoms is not made, repeat prescriptions leads to further health deterioration. The manufacturers of fluoroquinolone antibiotics have failed to warn both the public and the medical profession of serious long term physical and neurological injury. The manufacturers have minimized, distorted, and trivialized these serious adverse reactions. This deception and fraud not only costs the victim and their family but also the taxpayer in terms of increased medical care costs, disability payments, and lost productivity. I am signing this petition requesting that the United States Congress and the European Medicines Agency fully investigate the conduct and actions of the pharmaceutical manufacturers and the FDA. We ask that a recovery plan be instituted for victim's disabilities, income loss, and medical bills irrespective of statutes of limitations. Below is a link to an article written by Dr. Jay Cohen on fluoroquinolone antibiotic toxicity. http://www.medicationsense.com/articles/jan_mar_04/congress_ltr.html